TheStreet upgraded shares of Sharps Compliance (NASDAQ:SMED) from a d+ rating to a c- rating in a research report sent to investors on Wednesday, August 21st, TheStreetRatingsTable reports.
SMED has been the subject of a number of other reports. Roth Capital began coverage on Sharps Compliance in a research report on Wednesday, July 24th. They issued a buy rating and a $4.50 price objective for the company. Robert W. Baird started coverage on Sharps Compliance in a research report on Wednesday, July 24th. They issued a buy rating and a $4.50 price objective for the company. Zacks Investment Research lowered Sharps Compliance from a hold rating to a strong sell rating in a research report on Saturday, May 25th. Finally, Barrington Research restated a buy rating and set a $4.50 target price on shares of Sharps Compliance in a research report on Tuesday, May 21st. One investment analyst has rated the stock with a hold rating and three have given a buy rating to the company’s stock. Sharps Compliance presently has a consensus rating of Buy and a consensus price target of $4.38.
SMED stock traded up $0.16 during midday trading on Wednesday, hitting $4.06. The stock had a trading volume of 12,087 shares, compared to its average volume of 22,116. The firm has a market capitalization of $60.68 million, a price-to-earnings ratio of 376.00, a P/E/G ratio of 2.79 and a beta of 0.25. The stock has a 50-day simple moving average of $3.79 and a 200 day simple moving average of $3.59. Sharps Compliance has a 52 week low of $2.97 and a 52 week high of $4.47. The company has a current ratio of 2.29, a quick ratio of 1.83 and a debt-to-equity ratio of 0.04.Sharps Compliance (NASDAQ:SMED) last issued its quarterly earnings data on Wednesday, August 21st. The industrial products company reported $0.03 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.01 by $0.02. Sharps Compliance had a return on equity of 0.82% and a net margin of 0.48%. The company had revenue of $12.17 million during the quarter, compared to analysts’ expectations of $10.77 million. On average, equities analysts forecast that Sharps Compliance will post 0.06 EPS for the current year.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SMED. BlackRock Inc. lifted its stake in Sharps Compliance by 3.8% in the 2nd quarter. BlackRock Inc. now owns 108,739 shares of the industrial products company’s stock valued at $387,000 after acquiring an additional 4,013 shares in the last quarter. Lapides Asset Management LLC raised its stake in shares of Sharps Compliance by 13.3% during the 2nd quarter. Lapides Asset Management LLC now owns 164,700 shares of the industrial products company’s stock worth $586,000 after purchasing an additional 19,300 shares in the last quarter. Morgan Stanley raised its stake in shares of Sharps Compliance by 34.3% during the 2nd quarter. Morgan Stanley now owns 188,699 shares of the industrial products company’s stock worth $672,000 after purchasing an additional 48,199 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of Sharps Compliance by 8.3% during the 2nd quarter. Wells Fargo & Company MN now owns 424,814 shares of the industrial products company’s stock worth $1,512,000 after purchasing an additional 32,600 shares in the last quarter. Finally, Quantum Capital Management raised its stake in shares of Sharps Compliance by 0.6% during the 1st quarter. Quantum Capital Management now owns 522,569 shares of the industrial products company’s stock worth $1,913,000 after purchasing an additional 3,223 shares in the last quarter. Hedge funds and other institutional investors own 17.09% of the company’s stock.
Sharps Compliance Company Profile
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.
Further Reading: How Do You Make Money With Penny Stocks?
Receive News & Ratings for Sharps Compliance Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Sharps Compliance and related companies with MarketBeat.com’s FREE daily email newsletter.